BOLTON SECURITIES CORPORATION’s Ironwood Pharmaceuticals IRWD Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$58.8K	Buy	+14,800	New	+$61.8K	﹤0.01%	1295

Other funds holding IRWD

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's IRWD Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2026: 14,800 shares worth $58.8K. The stake represents ﹤0.01% of the portfolio and ranks #1295 among its holdings.

134 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

BOLTON SECURITIES CORPORATION held 14,800 shares of Ironwood Pharmaceuticals worth $58.8K as of Q3 2026.
Ironwood Pharmaceuticals was a new BOLTON SECURITIES CORPORATION position in Q3 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1295 holding.
134 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.